Blood Biomarkers for Detecting Minimal Residual Disease in Pediatric Sarcomas
Phase: Recruiting
Condition(s): Sarcoma
Other Study ID Number(s): MCC20320
What Is the Purpose of This Study?
To see if detecting cell-free plasma tumor DNA (ptDNA) and circulating tumor cells (CTC) can predict recurrence of disease in patients who are in radiographic remission 2-3 weeks after treatment. Plasma tumor DNA (ptDNA) is free floating DNA from the tumor found in the blood stream and circulating tumor cells.
Who Can Take Part in This Study?
People who may be eligible for this study:
- Have a new sarcoma diagnosis.
- Are ages 0 to 40 years.
What Will Happen During This Study?
Patients will undergo blood sample collection throughout the study. Timepoints of collection will depend on if local control is delayed or up front. Results from these blood draws will not be returned to the PI or the patient.
Principal Investigator
Discover More Research
Explore additional studies relating to sarcoma and solid tumorsYour Might Also Be Interested In
Exploring Pediatric Clinical Research
Clinical research involves the study of people, data or tissue samples to understand children’s health and diseases. It’s the foundation for medical advancement and plays a large role in improving health outcomes for children, teenagers and families.
Clinical Research: How We Keep Volunteers Safe
Clinical research is a type of research that involves people. Research participants help researchers to study new types of treatments, like new medicines or medical devices. It might even include changes in how people live or act, such as different ways to eat or exercise.
Stay Updated With Clinical Research. Follow @NCHClinicalResearch on Instagram!
Parents and caregivers can learn more about clinical research on our Instagram channel, @NCHClinicalResearch. You can be part of the clinical research that moves us forward in our journey to best outcomes for all children, everywhere.